Condensed Consolidated Balance Sheets - USD ($)	Sep. 30, 2020	Dec. 31, 2019
Current assets
Cash and cash equivalents	$ 2,391,208	$ 88,415
Other receivable	599,110	2,880
Other assets	102,190	52,686
Total current assets	3,092,508	143,981
Long-term assets
Long-term receivable		582,377
Property and equipment - net	23,741	36,568
Deferred compensation	1,458,333	2,083,334
Total long-term assets	1,482,074	2,702,279
TOTAL ASSETS	4,574,582	2,846,260
Current liabilities
Accounts payable	330,039	472,868
Accrued officer compensation	206,000	206,000
Notes payable including accrued interest of $356,446 at September 30, 2020 and $119,218 at December 31, 2019	7,515,018	3,467,890
Due to related parties	50,000	50,000
Accrued expenses	591,713	23,588
Accrued dividends	48,079	48,079
Total current liabilities	8,740,849	4,268,425
Long-term liabilities
Long-term notes payable net of unamortized debt discount	1,133,324	1,500,000
Total liabilities	9,874,173	5,768,425
Commitments and contingencies
Stockholders’ (deficit)
Series A Convertible Preferred Stock, $.001 par value, 2,000,000 shares authorized; 13,602 shares issued and outstanding at September 30, 2020 and at December 31, 2019	14	14
Common stock, $.001 par value, 500,000,000 shares authorized; 207,143,146 and 206,569,063 shares issued and outstanding at September 30, 2020 and at December 31, 2019, respectively	207,143	206,569
Additional paid-in capital	87,672,578	85,907,523
Accumulated deficit	(93,179,326)	(89,036,271)
Total stockholders’ (deficit)	(5,299,591)	(2,922,165)
TOTAL LIABILITIES AND STOCKHOLDERS’ (DEFICIT)	$ 4,574,582	$ 2,846,260